New Antibiotic Hits the Market to Tackle Stubborn UTIs
The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to ...
Medscape1d
Topical Antibiotic Treatment for Uncomplicated Skin and Skin Structure Infections: Review of the Literature
Because the effectiveness of the current oral options ... review discusses various topical antibiotic treatment options for uncomplicated skin infections, including over-the-counter and prescribed ...
Medpage Today on MSN12d
FDA Approves Novel Treatment for UTIs
The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) ...
McKnight's Long-Term Care News8d
FDA approves new antibiotic for uncomplicated UTIs
The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections ...
Becker's Hospital Review7d
FDA approves another new antibiotic
FDA approves new oral antibiotic for uncomplicated urinary tract infections in women with limited treatment options. Orylnvah shows superior response rates ...
Dr. Kube: Patient unhappy when told antibiotics not useful for treating his virus loses cool
An ED patient unhappy Dr. Kube would not give him antibiotics for his virus because they aren't useful began yelling and ...
FiercePharma12d
After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah
Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum ...
Daily8d
FDA approves new oral treatment for uncomplicated UTI in adult women
The US Food and Drug Administration has approved a new oral antibiotic for treatment of uncomplicated urinary tract ...
BioSpace9d
Iterum Wins FDA Approval For Oral UTI Antibiotic, Seeks ‘Strategic Transaction’ for Asset
Orlynvah is the first oral penem approved in the U.S. and Iterum Therapeutics’ first FDA-approved product. CEO Corey Fishman ...
WebMD9d
FDA OKs New Drug for Urinary Tract Infections
The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.
Fighting antibiotic resistance at the source – using machine learning to identify bacterial resistance genes and the drugs to block them
By analyzing the resistance genes and proteins of E. coli, researchers can optimize treatments to address both current and ...